The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis

OBJECTIVE: The last decade has seen an increase in the use of anti‐seizure medications (ASMs); however, the burden of treating drug‐resistant epilepsy has not fallen. We performed this meta‐analysis to evaluate the optimal dose of Perampanel (PER) as a new adjunctive treatment for drug‐resistant sei...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yiming, Zeng, Ya, Mu, Jie, Zhou, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159293/
https://www.ncbi.nlm.nih.gov/pubmed/34951748
http://dx.doi.org/10.1002/epi4.12574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159293/
https://www.ncbi.nlm.nih.gov/pubmed/34951748
http://dx.doi.org/10.1002/epi4.12574

Ejemplares similares